EA200600454A1 - Новый способ синтеза периндоприла и его фармацевтически приемлемых солей - Google Patents

Новый способ синтеза периндоприла и его фармацевтически приемлемых солей

Info

Publication number
EA200600454A1
EA200600454A1 EA200600454A EA200600454A EA200600454A1 EA 200600454 A1 EA200600454 A1 EA 200600454A1 EA 200600454 A EA200600454 A EA 200600454A EA 200600454 A EA200600454 A EA 200600454A EA 200600454 A1 EA200600454 A1 EA 200600454A1
Authority
EA
Eurasian Patent Office
Prior art keywords
perindopril
synthesis
pharmaceutically acceptable
acceptable salts
new method
Prior art date
Application number
EA200600454A
Other languages
English (en)
Other versions
EA008668B1 (ru
Inventor
Тьерри Дюбюффе
Жан-Пьер Лекув
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200600454A1 publication Critical patent/EA200600454A1/ru
Publication of EA008668B1 publication Critical patent/EA008668B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Способ синтеза периндоприла формулы (I)и его фармацевтически приемлемых солей.
EA200600454A 2003-08-29 2004-08-27 Новый способ синтеза периндоприла и его фармацевтически приемлемых солей EA008668B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03292132A EP1380591B1 (fr) 2003-08-29 2003-08-29 Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables
PCT/FR2004/002197 WO2005023842A1 (fr) 2003-08-29 2004-08-27 Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables

Publications (2)

Publication Number Publication Date
EA200600454A1 true EA200600454A1 (ru) 2006-08-25
EA008668B1 EA008668B1 (ru) 2007-06-29

Family

ID=29724624

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600454A EA008668B1 (ru) 2003-08-29 2004-08-27 Новый способ синтеза периндоприла и его фармацевтически приемлемых солей

Country Status (18)

Country Link
US (1) US7534896B2 (ru)
EP (1) EP1380591B1 (ru)
JP (1) JP4331206B2 (ru)
CN (1) CN100383160C (ru)
AR (1) AR045516A1 (ru)
AT (1) ATE310012T1 (ru)
AU (1) AU2004270428B2 (ru)
DE (1) DE60302287T2 (ru)
DK (1) DK1380591T3 (ru)
EA (1) EA008668B1 (ru)
ES (1) ES2252633T3 (ru)
HK (1) HK1096408A1 (ru)
MY (1) MY136638A (ru)
NZ (1) NZ545336A (ru)
PL (1) PL211508B1 (ru)
SI (1) SI1380591T1 (ru)
WO (1) WO2005023842A1 (ru)
ZA (1) ZA200601429B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1371659B1 (fr) * 2003-08-29 2005-10-12 Les Laboratoires Servier Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables
ES2314583T4 (es) 2005-01-06 2009-05-18 Ipca Laboratories Limited Proceso para sintesis de los derivados del acido (2s,3as,7as)-1-(s)-alanil-octahidro-1h-indol-2-carboxilico y su utilizacion en la sintesis de perindropil.
WO2009157018A2 (en) * 2008-06-24 2009-12-30 Matrix Laboratories Ltd Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
JP6753699B2 (ja) * 2016-05-27 2020-09-09 ミネベアミツミ株式会社 転がり軸受

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1321471T3 (da) 2003-03-12 2005-08-29 Servier Lab Ny syntesefremgangsmåde til perindopril og farmaceutisk acceptable salte heraf
DK1319668T3 (da) * 2003-03-12 2005-02-14 Servier Lab Fremgangsmåde til syntese af (2S, 3aS, 7aS)-1-((S)-alanyl)-octahydro-1H-indol-2-carboxylsyrederivater og anvendelse heraf ved syntese af perindopril
DK1367061T3 (da) * 2003-06-30 2006-05-15 Servier Lab Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
EP1371659B1 (fr) * 2003-08-29 2005-10-12 Les Laboratoires Servier Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables
ES2272922T3 (es) * 2003-08-29 2007-05-01 Les Laboratoires Servier Nuevo procedimiento de sintesis de perindopril y de sus sales farmaceuticamente aceptables.
DE60311942T2 (de) * 2003-11-19 2007-12-06 Les Laboratoires Servier Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen

Also Published As

Publication number Publication date
AU2004270428B2 (en) 2008-08-21
JP2007526902A (ja) 2007-09-20
JP4331206B2 (ja) 2009-09-16
CN1835966A (zh) 2006-09-20
DE60302287T2 (de) 2006-08-10
US20070010572A1 (en) 2007-01-11
US7534896B2 (en) 2009-05-19
AR045516A1 (es) 2005-11-02
EA008668B1 (ru) 2007-06-29
DE60302287D1 (de) 2005-12-22
EP1380591A1 (fr) 2004-01-14
SI1380591T1 (sl) 2006-02-28
EP1380591B1 (fr) 2005-11-16
MY136638A (en) 2008-11-28
ES2252633T3 (es) 2006-05-16
HK1096408A1 (en) 2007-06-01
DK1380591T3 (da) 2006-01-23
PL379628A1 (pl) 2006-10-30
ZA200601429B (en) 2007-05-30
PL211508B1 (pl) 2012-05-31
ATE310012T1 (de) 2005-12-15
CN100383160C (zh) 2008-04-23
WO2005023842A1 (fr) 2005-03-17
NZ545336A (en) 2009-03-31
AU2004270428A1 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
EA200201057A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
DE60317198D1 (de) Proteinkinaseinhibitoren
DE60331187D1 (de) Kinaseinhibitoren
CY1106471T1 (el) Νεα μεθοδος συνθεσης της περινδροπριλης και των φαρμακευτικως αποδεκτων αλατων αυτης
EA200800760A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA200601686A1 (ru) Замещенные производные морфолина и тиоморфолина
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
CY1106544T1 (el) Μεθοδος συνθεσεως υπερινδοπριλης και τα φαρμακευτικως αποδεκτα αλατα αυτης
EA200501925A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
CY1108238T1 (el) Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της
EA200501557A1 (ru) Новый способ синтеза (2s)-индолин-2-карбоновой кислоты и использование в синтезе периндоприла
EA200600456A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600455A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600454A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
MY135359A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
EA200501258A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600249A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600250A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200501299A1 (ru) Замещенные производные анилина
CY1106543T1 (el) Μεθοδος συνθεσεως υπερινδοπριλης και τα φαρμακευτικως αποδεκτα αλατα αυτης
EA200501256A1 (ru) НОВЫЙ СПОСОБ СИНТЕЗА (2S,3aS,7aS)-ПЕРГИДРОИНДОЛ-2-КАРБОНОВОЙ КИСЛОТЫ И ЕЁ СЛОЖНЫХ ЭФИРОВ, А ТАКЖЕ ИХ ПРИМЕНЕНИЕ ДЛЯ СИНТЕЗА ПЕРИНДОПРИЛА
EA200501499A1 (ru) ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ п-ДИАМИНОБЕНЗОЛА
EA200501669A1 (ru) Замещенные производные индолина и индола
MY137288A (en) New process for the synthesis of n-[(s)-1-ethoxycarbonylbutyl]-(s)-alanine and application in the synthesis of perindopril
MY137391A (en) New process for the synthesis of n-[(s)-1-ethoxycarbonylbutyl]-(s)-alanine and application in the synthesis of perindopril

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU